Short Interest in Cyanotech Co. (OTCMKTS:CYAN) Declines By 85.0%

Cyanotech Co. (OTCMKTS:CYAN) was the recipient of a large decrease in short interest during the month of August. As of August 31st, there was short interest totaling 653 shares, a decrease of 85.0% from the August 15th total of 4,353 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 14,470 shares, the short-interest ratio is presently 0.0 days.

Cyanotech Stock Performance

Cyanotech stock opened at $0.49 on Friday. The firm’s fifty day moving average price is $0.50 and its 200-day moving average price is $0.44. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.39 and a current ratio of 1.06. The stock has a market cap of $3.52 million, a P/E ratio of -1.94 and a beta of 0.07. Cyanotech has a fifty-two week low of $0.23 and a fifty-two week high of $0.57.

Cyanotech (OTCMKTS:CYAN) last announced its earnings results on Monday, June 29th. The biotechnology company reported $0.00 earnings per share (EPS) for the quarter. Cyanotech had a negative net margin of 0.25% and a negative return on equity of 0.86%.

About Cyanotech

Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids.